Tegafur

Spécifications

17902-23-7Numéro CAS

241-846-2Numéro CE

5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dioneNom IUPAC

C8H9FN2O3Formule chimique

200.17 g/molMasse molaire

tegafur; 17902-23-7; Ftorafur; Futraful; Sinoflurol; Fental; Neberk; Citofur; Lamar; Lifril; Coparogin; Furafluor; Furofutran; Nitobanil; Exonal; Fulfeel; Tefsiel C; Riol; Florafur; FT-207; Franrose; Sunfural; Fulaid; MJF-12264; Atillon; Tegafurum; 1-(2-Tetrahydrofuryl)-5-fluorouracil; NSC-148958; 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-; URACIL, 5-FLUORO-1-(TETRAHYDRO-2-FURYL)-; 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione; 5-fluoro-1-tetrahydrofuran-2-yl-pyrimidine-2,4-dione; 1548R74NSZ; FT207; TS-1 component tegafur; FT 207; N1-(2'-Tetrahydrofuryl)-5-fluorouracil; TEYSUNO COMPONENT TEGAFUR; DTXSID001009966; N1-(2'-Furanidyl)-5-fluorouracil; 5-fluoro-1-(tetrahydro-2-furyl)-uracil; 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione; J356.722B; Tefsiel; NSC148958; Ftoralon; Ftoral; Utefos; 1-(Tetrahydro-2-furanyl)-5-fluorouracil; RefChem:891301; DTXCID701305; L01BC03; WR-220066; 5-Fluoro-1-((2RS)-tetrahydrofuran-2-yl)uracil; 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-(1H,3H)-pyrimidinedione; BMS-200604; Fluorofur; 5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 5-Fluoro-1-(tetrahydro-2-furyl)uracil; Franroze; Furflucil; Sunfral; Phthorafur; 5-FLUORO-1-(TETRAHYDRO-2-FURFURYL)URACIL; C8H9FN2O3; MFCD00012351; 1-(Tetrahydrofuran-2-yl)-5-fluorouracil; 5-Fluoro-1-(tetrahydrofuran-2-yl)uracil; N1-(2-tetrahydrofuryl)-5-fluorouracil; Uracil, 1-(tetrahydrofuran-2-yl)-5-fluoro-; 5-fluoro-1-(oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione; 5-Fluoro-1-(tetrahydro-3-furyl)uracil; 1-(Tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione; MLS000069497; Fluorafur; SMR000059106; 2,4(1H,3H)Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-; Racemic Ftorafur; 82294-77-7; Phthorafur [Czech]; FT-207 (NSC 148958); Tegafurum [INN-Latin]; NSC 148958; CCRIS 2762; EINECS 241-846-2; 79107-97-4; BRN 0525766; Tegafuris; UNII-1548R74NSZ; Furflucil;; Ftorafur;; Futraful;; Citofur;; Tegafur?; Neberk;; N(sub 1)-(2-Tetrahydrofuryl)-5-fluorouracil; Tegafur [USAN:INN:BAN:JAN]; 1-(2-TETRAHYDROFORMYL)-5-FLUOROURACIL; N(sub 1)-(2'-Furanidyl)-5-fluouracil [Czech]; NCGC00159418-02; NCGC00159418-05; Atillon (TN); Tegafur (Standard); S-1 component tegafur; N(sub 1)-(2'-Furanidyl)-5-fluouracil; TS-1 (Salt/Mix); TEGAFUR [USAN]; TEGAFUR [INN]; TEGAFUR [JAN]; TEGAFUR [MI]; Opera_ID_1726; TEGAFUR [MART.]; TEGAFUR [WHO-DD]; UPCMLD-DP063; SCHEMBL4552; TEGAFUR [EMA EPAR]; 5-24-06-00285 (Beilstein Handbook Reference); MLS000759414; MLS001076521; MLS001424119; CHEMBL20883; Tegafur (JP18/USAN/INN); F-5-FU; orb1308791; orb3141400; SCHEMBL27802890; UPCMLD-DP063:001; CHEBI:32188; GTPL10513; GLXC-07064; HMS1665I05; HMS2051B15; HMS2090K04; HMS2232E05; HMS3371H21; HMS3393B15; HMS3654P13; HMS3715D14; HMS5079B09; N1-(2'-Furanidyl)-5-fluouracil; CCG-50110; EBC-03486; HY-17400R; STK528044; Tegafur, >=98% (HPLC), powder; 5-Fluoro-1-(2-tetrahydrofuryl)uracil; AKOS000121279; AC-2112; CCG-100959; CS-1128; DB09256; FF08013; NC00209; 1-(tetrahydro-2-furyl)-5-fluorouracil; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, didehydroderiv.; 5-fluoro-1-(2-tetrahydrofuranyl)uracil; N1 -(2-tetrahydrofuryl)-5-fluorouracil; NCGC00159418-04; NCGC00159418-13; AS-13528; BP-58663; HY-17400; SY057932; Tegafur (FT-207; NSC 148958); F7657; NS00007105; T1378; EN300-21668; D01244; AB00572620-15; F815549; Q413370; SR-01000639511; SR-01000639511-1; SR-01000639511-4; 5-Fluoro-1-(oxolan-2-yl)pyrimidine-2,4(1H,3H)-dione; Z104508106; 5-fluoro-1-tetrahydro-furan-2-yl-1H-pyrimidine-2,4-dione; pyrimidine-2,4(1H,3H)-dione, 5-fluoro-1-(2-oxolanyl)-; 5-Fluoro-1-tetrahydro-2-furanyl-2,4(1H,3H)-pyrimidinedione; 2, 4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-Synonymes